Novaliq's NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand | Business Wire
Press Releases - Novaliq
Management - Novaliq
Products - Novaliq
Novaliq to develop innovative eye drop products - Healthcare industry
Investor Relation - Novaliq
Anterior Segment Company Showcase - Novaliq GmbH
Anterior Segment Company Showcase - Novaliq GmbH
Novaliq schließt Rekrutierung der zweiten Phase III-Studie für CyclASol® zur Behandlung von Trockenes Auge (Keratoconjunctivitis sicca - „KCS", oder auch Syndrom des trockenen Auges) ab
Startseite - Novaliq
Novatears - Novaliq
EvoTears® OMEGA - EvoTears®
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING